[1]潘晓帆 秦琳 韩杨 朱晓华 周燕 郭强.阿替普酶溶栓治疗急性脑梗死早期神经功能恶化的相关危险因素分析[J].卒中与神经疾病杂志,2019,26(02):140-142.[doi:10.3969/j.issn.1007-0478.2019.02.002]
　Pan Xiaofan,Qin Lin,Han Yang,et al.The analysis of the risk factor for early neurologic deterioration in using Alteplase Thrombolysis to treat acute cerebral infarction[J].Stroke and Nervous Diseases,2019,26(02):140-142.[doi:10.3969/j.issn.1007-0478.2019.02.002]
点击复制

阿替普酶溶栓治疗急性脑梗死早期神经功能恶化的相关危险因素分析()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第26卷
期数:
2019年02期
页码:
140-142
栏目:
论 著
出版日期:
2019-04-20

文章信息/Info

Title:
The analysis of the risk factor for early neurologic deterioration in using Alteplase Thrombolysis to treat acute cerebral infarction
文章编号:
1007-0478(2019)02-0140-04
作者:
潘晓帆 秦琳 韩杨 朱晓华 周燕 郭强
214105 江苏省无锡市东南大学附属中大医院无锡分院神经内科(潘晓帆 秦琳 韩杨 朱晓华 周燕); 苏州大学附属第一医院重症医学科(郭强)
Author(s):
Pan Xiaofan; Qin Lin; Han Yang; et al.
Department of Neurology,Wuxi Branch of Zhongda Hospital Southeast University,Wuxi 214105
关键词:
阿替普酶 溶栓 急性脑梗死 早期神经功能恶化 危险因素
Keywords:
Alteplase Thrombolysis Acute cerebral infarction Early deterioration of neurological function Risk factors
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2019.02.002
文献标志码:
A
摘要:
目的 分析阿替普酶溶栓治疗急性脑梗死早期神经功能恶化的相关危险因素。方法 选择2013年1月-2018年6月本院神经内科收治的发病4.5 h内给予阿替普酶溶栓治疗的急性脑梗死患者114例,根据阿替普酶治疗后是否发生早期神经功能恶化(Early neurologic deterioration,END)分为恶化组(43例)和非恶化组(71例),收集2组临床基线资料,分析阿替普酶溶栓治疗患者发生END的危险因素。结果 恶化组饮酒人数、吞咽功能障碍人数、责任大血管闭塞数、心源性脑栓塞数、白细胞计数、TC、LDL-C、脂蛋白(a)、ApoB、肌酐水平等指标均显著高于非恶化组(P均<0.05),而HDL-C水平明显低于非恶化组(P<0.05),而其它基线资料比较无明显差异(P均>0.05); Logistic回归分析显示脂蛋白(a)、HDL-C水平、责任大血管闭塞、心源性脑栓塞均与患者溶栓后发生END显著相关(P<0.05)。结论 脂蛋白(a)及HDL-C水平异常、责任大血管闭塞、心源性脑栓塞等均为溶栓治疗急性脑梗死END的独立危险因素。
Abstract:
ObjectiveTo analyze the risk factor for early neurologic deterioration in using Alteplase thrombolysis to treat acute cerebral infarction.Methods 114 patients with acute cerebral infarction were selected,they were treated alteplase thrombolytic therapy within 4.5 h of the onset at the department of neurology in our hospital from January 2013 to June 2018,and they were divided into the deterioration group(43 cases)and the non-deterioration group(71 cases)according to whether Early neurologic deterioration occurred after alteplase treatment.The clinical baseline data of the two groups were collected and compared,and the risk factors of END in patients treated with alteplase thrombolysis were analyzed.Results The number of alcohol consumption,swallowing dysfunction,major vessel occlusion,and cardiogenic cerebral embolism,and white blood cell count,TC value,ldl-c value,lipoprotein(a)value,ApoB,creatinine value in the deteriorating group were significantly higher than those in the non-deteriorating group(all P<0.05),however HDL-C level was significantly lower than that in the non-deteriorating group(P<0.05),and there were no statistically significant differences in other baseline data(all P>0.05); Logistic regression analysis showed that lipoprotein(a)level,hdl-c level,responsible large vessel occlusion,and cardiogenic cerebral embolism were all significantly correlated with the END after thrombolysis(P<0.05).Conclusion Lipoprotein(a)and HDL-C abnormalities,responsible large vessels occlusion,and cardiogenic cerebral embolism were all independent risk factors for END in Acute cerebral infarction after alteplase treatment.

参考文献/References:

[1] 王黎明,张雪玲,林晓光,等.踝肱指数与急性缺血性卒中患者早期神经功能恶化的相关性[J].国际脑血管病杂志,2015(3):176-179.
[2] 沈东超,王子璇,肖伏龙,等.急性缺血性卒中静脉应用阿替普酶纳入及排除标准的科学声明(第四部分)?美国心脏协会/美国卒中协会致医疗卫生专业人员的声明[J].中国卒中杂志,2016,11(5):404-407.
[3] 孟佳雪,贺帅,谢惠芳,等.阿替普酶治疗急性脑梗死患者的出血不良反应影响因素分析[J].中国临床药理学杂志,2018,34(14):1595-1597.
[4] 钟义良,张融融,黄思源,等.急性脑梗死患者血清陷窝蛋白1水平与早期神经功能恶化的关系[J].上海交通大学学报:医学版,2017,37(12):1678-1681.
[5] 黄松.阿替普酶联合丁苯酞对脑梗死的疗效和炎性因子的影响[J].基因组学与应用生物学,2017,36(1):18-22.
[6] Siegler J E,Boehme A K,Kumar A D,et al.Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke[J].Journal of Stroke & Cerebrovascular Diseases,2013,22(7):E207-E213.
[7] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华医学信息导报,2010,25(14):16-19.
[8] 李安民,陈合成,关文标,等.阿替普酶溶栓治疗对老年急性脑梗死患者神经功能、颅内血流动力学及生活质量的影响[J].中国老年学杂志,2017,37(19):4786-4788.
[9] 王洪敏.老年急性脑梗死患者神经功能恶化危险因素分析[J].中国老年学杂志,2012,32(3):470-473.
[10] 郭洪权,李华,谢怡,等.大脑中动脉供血区急性脑梗死患者早期神经功能恶化危险因素分析[J].中国脑血管病杂志,2017,14(1):15-19.
[11] 朱烨,吴雅利,李宝香,等.丁苯酞联合阿替普酶对急性脑梗死患者神经功能,认知功能和Hcy等血清学指标的影响[J].中国药房,2018,29(8):1095-1098.
[12] 王黎明,张雪玲,林晓光,等.血清糖化血红蛋白水平与急性脑梗死早期神经功能恶化的相关性分析[J].中国脑血管病杂志,2016,13(7):348-352.
[13] 华键,周其达.急性脑梗死早期神经功能恶化与高密度脂蛋白胆固醇及脂蛋白(a)的关系[J].中华老年心脑血管病杂志,2018,20(4):405-407.
[14] Ahn N,Kim K.High-density lipoprotein cholesterol(HDL-C)in cardiovascular disease:effect of exercise training[J].Integr Med Res,2016,5(3):212-215.
[15] 严洪新,罗建华,余练.急性脑梗死患者行尿激酶静脉溶栓治疗时早期神经功能恶化的危险因素分析[J].血栓与止血学,2018,24(1):17-20.
[16] 张瑜,程曼,姚源蓉.复发性脑梗死患者发生早期神经功能恶化的相关危险因素分析[J].实用医学杂志,2016,32(7):1037-1040.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金青年项目(81300040) (2018-09-21收稿) 页码142+147
更新日期/Last Update: 2019-04-20